GLP-1 drugs can interfere with FDG-PET-CT scans, study says

GLP-1 receptor agonists may interfere with the interpretation of fluorodeoxyglucose (FDG) positron emission tomography–computed tomography (PET-CT) cancer scans, according to new findings presented this week at the 38th Annual Congress of the…